Recent advances in the treatment of pancreatic cancer

por Roth, Marc T, Cardin, Dana B, Berlin, Jordan D
Publicado 2020

Trends in the Incidence and Treatment of Early-Onset Pancreatic Cancer

por LaPelusa, Michael, Shen, Chan, Arhin, Nina D., Cardin, Dana, Tan, Marcus, Idrees, Kamran, Geevarghese, Sunil, Chakravarthy, Bapsi, Berlin, Jordan, Eng, Cathy
Publicado 2022

Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation

por Kim, Joseph W., Cardin, Dana B., Vaishampayan, Ulka N., Kato, Shumei, Grossman, Steven R., Glazer, Peter M., Shyr, Yu, Ivy, S. Percy, LoRusso, Patricia M.
Publicado 2021

Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer

por Cardin, Dana B, Goff, Laura, Li, Chung-I, Shyr, Yu, Winkler, Charles, DeVore, Russell, Schlabach, Larry, Holloway, Melanie, McClanahan, Pam, Meyer, Krista, Grigorieva, Julia, Berlin, Jordan, Chan, Emily
Publicado 2014

A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic...

por Davis, S. Lindsey, Cardin, Dana B., Shahda, Safi, Lenz, Heinz-Josef, Dotan, Efrat, O’Neil, Bert H., Kapoun, Ann M., Stagg, Robert J., Berlin, Jordan, Messersmith, Wells A., Cohen, Steven J.
Publicado 2019

A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers

por Goff, Laura W., Cardin, Dana B., Whisenant, Jennifer G., Du, Liping, Koyama, Tatsuki, Dahlman, Kimberly B., Salaria, Safia N., Young, Ruth T., Ciombor, Kristen K., Gilbert, Jill, Smith, Stephen James, Chan, Emily, Berlin, Jordan
Publicado 2016

Thymidylate Synthase Genotype-Directed Chemotherapy for Patients with Gastric and Gastroesophageal Junction Cancers

por Goff, Laura W., Thakkar, Nilay, Du, Liping, Chan, Emily, Tan, Benjamin R., Cardin, Dana B., McLeod, Howard L., Berlin, Jordan D., Zehnbauer, Barbara, Fournier, Chloe, Picus, Joel, Wang-Gillam, Andrea, Lee, Wooin, Lockhart, A. Craig
Publicado 2014

External Validation of a Clinical Score for Patients With Neuroendocrine Tumors Under Consideration for Peptide Receptor Radionuclide Therapy

por Das, Satya, Chauhan, Aman, Du, Liping, Thomas, Katharine E., Jacob, Aasems, Schad, Aimee, Jain, Shikha, Jessop, Aaron, Shah, Chirayu, Eisner, David, Cardin, Dana B., Ciombor, Kristen K., Goff, Laura W., Bradshaw, Marques, Delbeke, Dominique, Sandler, Martin, Ramirez, Robert A., Berlin, Jordan
Publicado 2022

First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors

por Davis, Elizabeth J, Martin-Liberal, Juan, Kristeleit, Rebecca, Cho, Daniel C, Blagden, Sarah P, Berthold, Dominik, Cardin, Dana B, Vieito, Maria, Miller, Rowan E, Hari Dass, Prashanth, Orcurto, Angela, Spencer, Kristen, Janik, John E, Clark, Jason, Condamine, Thomas, Pulini, Jennifer, Chen, Xuejun, Mehnert, Janice M
Publicado 2022